• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人工智能在肝脏疾病中的应用:来自2024年欧洲肝脏研究学会大会的一项调查。

Use of artificial intelligence for liver diseases: A survey from the EASL congress 2024.

作者信息

Žigutytė Laura, Sorz-Nechay Thomas, Clusmann Jan, Kather Jakob Nikolas

机构信息

Else Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.

Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.

出版信息

JHEP Rep. 2024 Sep 6;6(12):101209. doi: 10.1016/j.jhepr.2024.101209. eCollection 2024 Dec.

DOI:10.1016/j.jhepr.2024.101209
PMID:39583096
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11585758/
Abstract

Artificial intelligence (AI) methods enable humans to analyse large amounts of data, which would otherwise not be feasibly quantifiable. This is especially true for unstructured visual and textual data, which can contain invaluable insights into disease. The hepatology research landscape is complex and has generated large amounts of data to be mined. Many open questions can potentially be addressed with existing data through AI methods. However, the field of AI is sometimes obscured by hype cycles and imprecise terminologies. This can conceal the fact that numerous hepatology research groups already use AI methods in their scientific studies. In this review article, we aim to assess the contemporaneous use of AI methods in hepatology in Europe. To achieve this, we systematically surveyed all scientific contributions presented at the EASL Congress 2024. Out of 1,857 accepted abstracts (1,712 posters and 145 oral presentations), 6 presentations (∼4%) and 69 posters (∼4%) utilised AI methods. Of these, 55 posters were included in this review, while the others were excluded due to missing posters or incomplete methodologies. Finally, we summarise current academic trends in the use of AI methods and outline future directions, providing guidance for scientific stakeholders in the field of hepatology.

摘要

人工智能(AI)方法使人类能够分析大量数据,否则这些数据将无法进行可行的量化。对于非结构化的视觉和文本数据而言尤其如此,这些数据可能包含对疾病的宝贵见解。肝病学研究领域十分复杂,已经产生了大量有待挖掘的数据。通过人工智能方法,利用现有数据有可能解决许多悬而未决的问题。然而,人工智能领域有时会被炒作周期和不精确的术语所掩盖。这可能会掩盖众多肝病学研究小组已经在其科学研究中使用人工智能方法这一事实。在这篇综述文章中,我们旨在评估欧洲肝病学领域对人工智能方法的当前应用情况。为实现这一目标,我们系统地调查了在2024年欧洲肝脏研究学会(EASL)大会上发表的所有科学成果。在1857篇被接受的摘要(1712篇海报展示和145篇口头报告)中,有6篇口头报告(约4%)和69篇海报展示(约4%)使用了人工智能方法。其中,55篇海报展示被纳入本综述,其他的则因海报缺失或方法不完整而被排除。最后,我们总结了当前使用人工智能方法的学术趋势并概述了未来方向,为肝病学领域的科研利益相关者提供指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa01/11585758/89ea4b0154d6/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa01/11585758/670011592fcc/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa01/11585758/d0c596fcb0c3/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa01/11585758/a9dda8871cda/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa01/11585758/909991c11789/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa01/11585758/89ea4b0154d6/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa01/11585758/670011592fcc/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa01/11585758/d0c596fcb0c3/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa01/11585758/a9dda8871cda/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa01/11585758/909991c11789/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa01/11585758/89ea4b0154d6/gr5.jpg

相似文献

1
Use of artificial intelligence for liver diseases: A survey from the EASL congress 2024.人工智能在肝脏疾病中的应用:来自2024年欧洲肝脏研究学会大会的一项调查。
JHEP Rep. 2024 Sep 6;6(12):101209. doi: 10.1016/j.jhepr.2024.101209. eCollection 2024 Dec.
2
Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for clinicians.评估慢性阻塞性肺疾病干预措施的比较效果:面向临床医生的网状Meta分析教程
Respir Res. 2024 Dec 21;25(1):438. doi: 10.1186/s12931-024-03056-x.
3
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.暴力死亡监测——2022年全国暴力死亡报告系统,50个州、哥伦比亚特区和波多黎各
MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1.
4
AI-Driven Antimicrobial Peptide Discovery: Mining and Generation.人工智能驱动的抗菌肽发现:挖掘与生成
Acc Chem Res. 2025 Jun 17;58(12):1831-1846. doi: 10.1021/acs.accounts.0c00594. Epub 2025 Jun 3.
5
Stakeholders' perceptions and experiences of factors influencing the commissioning, delivery, and uptake of general health checks: a qualitative evidence synthesis.利益相关者对影响一般健康检查的委托、提供和接受因素的看法与体验:一项定性证据综合分析
Cochrane Database Syst Rev. 2025 Mar 20;3(3):CD014796. doi: 10.1002/14651858.CD014796.pub2.
6
Aural toilet (ear cleaning) for chronic suppurative otitis media.慢性化脓性中耳炎的耳道清理(耳部清洁)
Cochrane Database Syst Rev. 2025 Jun 9;6(6):CD013057. doi: 10.1002/14651858.CD013057.pub3.
7
Redefining Mentorship in Medical Education with Artificial Intelligence: A Delphi Study on the Feasibility and Implications.利用人工智能重新定义医学教育中的导师指导:关于可行性和影响的德尔菲研究
Teach Learn Med. 2025 Jun 18:1-11. doi: 10.1080/10401334.2025.2521001.
8
Mucolytics for children with chronic suppurative lung disease.用于患有慢性化脓性肺病儿童的黏液溶解剂。
Cochrane Database Syst Rev. 2025 Mar 28;3(3):CD015313. doi: 10.1002/14651858.CD015313.pub2.
9
Cauliflower leaf diseases: A computer vision dataset for smart agriculture.花椰菜叶部病害:一个用于智慧农业的计算机视觉数据集。
Data Brief. 2025 Apr 28;60:111594. doi: 10.1016/j.dib.2025.111594. eCollection 2025 Jun.
10
Journals Operating Predatory Practices Are Systematically Eroding the Science Ethos: A Gate and Code Strategy to Minimise Their Operating Space and Restore Research Best Practice.采用掠夺性做法的期刊正在系统性地侵蚀科学精神:一种减少其运营空间并恢复研究最佳实践的把关与编码策略。
Microb Biotechnol. 2025 Jun;18(6):e70180. doi: 10.1111/1751-7915.70180.

引用本文的文献

1
[Surgical management of giant hemangiomas in the caudate lobe: an overview on the intraoperative management and role of artificial intelligence (AI) in improvement of the surgical results].尾状叶巨大血管瘤的外科治疗:术中管理及人工智能(AI)在改善手术效果中的作用概述
Chirurgie (Heidelb). 2025 Aug 12. doi: 10.1007/s00104-025-02361-5.
2
Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells.肝脏内稳态与疾病中的炎症和免疫:肝细胞、非实质细胞与免疫细胞的关联
Cell Mol Immunol. 2025 Jul 1. doi: 10.1038/s41423-025-01313-7.
3
Immunopathogenic mechanisms and immunoregulatory therapies in MASLD.

本文引用的文献

1
Predicting post-hepatectomy liver failure in patients with hepatocellular carcinoma: nomograms based on deep learning analysis of gadoxetic acid-enhanced MRI.预测肝细胞癌患者肝切除术后肝衰竭:基于钆塞酸二钠增强MRI深度学习分析的列线图
Eur Radiol. 2025 May;35(5):2769-2782. doi: 10.1007/s00330-024-11173-w. Epub 2024 Nov 12.
2
Privacy-preserving large language models for structured medical information retrieval.用于结构化医学信息检索的隐私保护大语言模型
NPJ Digit Med. 2024 Sep 20;7(1):257. doi: 10.1038/s41746-024-01233-2.
3
A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B.
非酒精性脂肪性肝炎的免疫致病机制及免疫调节疗法
Cell Mol Immunol. 2025 Jun 10. doi: 10.1038/s41423-025-01307-5.
4
ASS1 is a hub gene and possible therapeutic target for regulating metabolic dysfunction-associated steatotic liver disease modulated by a carbohydrate-restricted diet.ASS1是一个枢纽基因,也是通过碳水化合物限制饮食调节代谢功能障碍相关脂肪性肝病的潜在治疗靶点。
Mol Divers. 2025 Apr 17. doi: 10.1007/s11030-025-11187-6.
5
Gut Microbiome-Liver-Brain axis in Alcohol Use Disorder. The role of gut dysbiosis and stress in alcohol-related cognitive impairment progression: possible therapeutic approaches.酒精使用障碍中的肠道微生物群-肝脏-大脑轴。肠道微生物失调和应激在酒精相关认知障碍进展中的作用:可能的治疗方法。
Neurobiol Stress. 2025 Feb 8;35:100713. doi: 10.1016/j.ynstr.2025.100713. eCollection 2025 Mar.
6
Advancements in Artificial Intelligence-Enhanced Imaging Diagnostics for the Management of Liver Disease-Applications and Challenges in Personalized Care.人工智能增强成像诊断在肝病管理中的进展——个性化医疗中的应用与挑战
Bioengineering (Basel). 2024 Dec 9;11(12):1243. doi: 10.3390/bioengineering11121243.
一种用于预测慢性乙型肝炎功能性治愈后肝脏相关结局的机器学习模型。
J Hepatol. 2025 Feb;82(2):235-244. doi: 10.1016/j.jhep.2024.08.016. Epub 2024 Aug 31.
4
Evaluation of four chatbots in autoimmune liver disease: A comparative analysis.四种聊天机器人在自身免疫性肝病中的评估:一项比较分析。
Ann Hepatol. 2024 Aug 13;30(1):101537. doi: 10.1016/j.aohep.2024.101537.
5
Comparative Evaluation of LLMs in Clinical Oncology.临床肿瘤学中大型语言模型的比较评估
NEJM AI. 2024 May;1(5). doi: 10.1056/aioa2300151. Epub 2024 Apr 16.
6
Evaluation of ChatGPT as a Counselling Tool for Italian-Speaking MASLD Patients: Assessment of Accuracy, Completeness and Comprehensibility.将ChatGPT评估为意大利语母语的非酒精性脂肪性肝病(MASLD)患者的咨询工具:准确性、完整性和可理解性评估。
J Pers Med. 2024 May 26;14(6):568. doi: 10.3390/jpm14060568.
7
Correspondence to editorial on "Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma".致关于“早期肝细胞癌患者的传统风险评分和基于机器学习的风险评分”的社论的信函。
Clin Mol Hepatol. 2024 Oct;30(4):1016-1018. doi: 10.3350/cmh.2024.0365. Epub 2024 May 20.
8
A guide to artificial intelligence for cancer researchers.癌症研究人员的人工智能指南。
Nat Rev Cancer. 2024 Jun;24(6):427-441. doi: 10.1038/s41568-024-00694-7. Epub 2024 May 16.
9
Metabolic dysfunction-associated steatotic liver disease: A silent pandemic.代谢功能障碍相关脂肪性肝病:一场无声的大流行。
World J Hepatol. 2024 Apr 27;16(4):511-516. doi: 10.4254/wjh.v16.i4.511.
10
FDA approves first MASH drug.美国食品药品监督管理局批准首款MASH药物。
Nat Biotechnol. 2024 Apr;42(4):540. doi: 10.1038/s41587-024-02220-4.